| scholarly article | Q13442814 |
| P356 | DOI | 10.4049/JIMMUNOL.1001860 |
| P698 | PubMed publication ID | 20810982 |
| P50 | author | Constadina Panagiotopoulos | Q38546313 |
| John J. Priatel | Q44189867 | ||
| Megan K. Levings | Q47345521 | ||
| Rusung Tan | Q55278834 | ||
| Sarah Q Crome | Q64515034 | ||
| P2093 | author name string | Qin Ouyang | |
| Lixin Xu | |||
| Kyra B Berg | |||
| Huilian Qin | |||
| Ashish K Marwaha | |||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| P304 | page(s) | 3814-3818 | |
| P577 | publication date | 2010-09-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Cutting edge: Increased IL-17-secreting T cells in children with new-onset type 1 diabetes | |
| P478 | volume | 185 |
| Q35980738 | ATP binding cassette transporter G1 deletion induces IL-17-dependent dysregulation of pulmonary adaptive immunity. |
| Q38195946 | Advances in the cellular immunological pathogenesis of type 1 diabetes |
| Q34138598 | Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide |
| Q38236300 | Alteration of regulatory T cells in type 1 diabetes mellitus: a comprehensive review. |
| Q39644535 | Altered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA). |
| Q59791453 | An Insight Into the Intestinal Web of Mucosal Immunity, Microbiota, and Diet in Inflammation |
| Q38091182 | Anti-cytokine therapies in T1D: Concepts and strategies |
| Q28080791 | Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases |
| Q38030480 | Autologous regulatory T cells for the treatment of type 1 diabetes |
| Q38715502 | Blocking IL-17A Alleviates Diabetic Retinopathy in Rodents |
| Q38535279 | CD4 T cell differentiation in type 1 diabetes. |
| Q35178495 | CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game |
| Q64235971 | Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account? |
| Q38071420 | Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus. |
| Q35612414 | Central role for interleukin-2 in type 1 diabetes |
| Q35976580 | Children with islet autoimmunity and enterovirus infection demonstrate a distinct cytokine profile |
| Q37335056 | Cholinergic Stimulation Prevents the Development of Autoimmune Diabetes: Evidence for the Modulation of Th17 Effector Cells via an IFNγ-Dependent Mechanism |
| Q37664261 | Consumption of acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. |
| Q64112720 | Different distribution of mucosal-associated invariant T cells within the human cecum and colon |
| Q90324457 | Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes |
| Q45174166 | Double deficiency in IL-17 and IFN-γ signalling significantly suppresses the development of diabetes in the NOD mouse |
| Q42369885 | Early-Life Nutritional Factors and Mucosal Immunity in the Development of Autoimmune Diabetes. |
| Q38189119 | Effector and regulatory T cell subsets in diabetes-associated inflammation. Is there a connection with ST2/IL-33 axis? Perspective. |
| Q51526083 | Elevated Levels of T-helper 17-associated Cytokines in Diabetes Type I Patients: Indicators for Following the Course of Disease. |
| Q41751738 | Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression |
| Q35405076 | Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes |
| Q43855747 | Expansion of activated regulatory T cells by myeloid-specific chemokines via an alternative pathway in CSF of bacterial meningitis patients |
| Q36184263 | Expression of PD-1 Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Mellitus. |
| Q61811655 | FOXP3+ Regulatory T Cell Compartment Is Altered in Children With Newly Diagnosed Type 1 Diabetes but Not in Autoantibody-Positive at-Risk Children |
| Q36345714 | From biomarkers to a clue of biology: a computation-aided perspective of immune gene expression profiles in human type 1 diabetes |
| Q91711933 | Fungal Dysbiosis and Intestinal Inflammation in Children With Beta-Cell Autoimmunity |
| Q35551328 | Glucocorticoid-induced tumour necrosis factor receptor-related protein: a key marker of functional regulatory T cells. |
| Q34785097 | Gut microbiota and type 1 diabetes |
| Q38216200 | Heterogeneity in the differentiation and function of CD8⁺ T cells |
| Q39356640 | High-dose cholecalciferol supplementation significantly increases peripheral CD4⁺ Tregs in healthy adults without negatively affecting the frequency of other immune cells |
| Q45281719 | Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets |
| Q38833064 | IL-17+ CD8+ T cells: Differentiation, phenotype and role in inflammatory disease |
| Q37538552 | IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling |
| Q98205381 | IL-17F induces inflammation, dysfunction and cell death in mouse islets |
| Q35153018 | IL-21 production by CD4+ effector T cells and frequency of circulating follicular helper T cells are increased in type 1 diabetes patients |
| Q33603302 | ISA-2011B, a Phosphatidylinositol 4-Phosphate 5-Kinase α Inhibitor, Impairs CD28-Dependent Costimulatory and Pro-inflammatory Signals in Human T Lymphocytes |
| Q47702857 | Imbalance between Subpopulations of Regulatory T Cells in Patients with Acute Exacerbation of COPD. |
| Q42282784 | Imbalance between circulating CD4+ regulatory T and conventional T lymphocytes in patients with HBV-related acute-on-chronic liver failure |
| Q45910638 | Imbalance between subpopulations of regulatory T cells in COPD. |
| Q38182297 | Immune modulation in humans: implications for type 1 diabetes mellitus. |
| Q34987849 | Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes |
| Q34981029 | Increased systemic Th17 cytokines are associated with diastolic dysfunction in children and adolescents with diabetic ketoacidosis |
| Q37996976 | Inflammation and type one diabetes |
| Q55337327 | Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes. |
| Q35902052 | Interleukin-35 administration counteracts established murine type 1 diabetes--possible involvement of regulatory T cells |
| Q37980043 | Is the origin of type 1 diabetes in the gut? |
| Q37598361 | Islet antigen-specific Th17 cells can induce TNF-α-dependent autoimmune diabetes |
| Q27008200 | Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity |
| Q92319311 | Mechanisms of human FoxP3+ Treg cell development and function in health and disease |
| Q34615216 | Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases |
| Q36698793 | Mechanistic basis of immunotherapies for type 1 diabetes mellitus |
| Q36995345 | Obstacles and opportunities for targeting the effector T cell response in type 1 diabetes |
| Q64115025 | Pancreatic autoantibodies and CD14+CD16+ monocytes subset are associated with the impairment of ß-cell function after simultaneous pancreas-kidney transplantation |
| Q37088180 | Pathogenic mechanisms in type 1 diabetes: the islet is both target and driver of disease |
| Q28582005 | Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death |
| Q42844120 | Plasma levels of IL-17, VEGF, and adrenomedullin and S-cone dysfunction of the retina in children and adolescents without signs of retinopathy and with varied duration of diabetes. |
| Q48312123 | Possible involvement of chemokine C-C receptor 7- programmed cell death-1+ follicular helper T-cell subset in the pathogenesis of autoimmune hepatitis. |
| Q35161591 | Potential role of IL-17-producing iNKT cells in type 1 diabetes |
| Q39039728 | Pre-diagnostic genotyping identifies T1D subjects with impaired Treg IL-2 signaling and an elevated proportion of FOXP3+IL-17+ cells |
| Q33677473 | Prevention and treatment of diabetes with resveratrol in a non-obese mouse model of type 1 diabetes |
| Q35088799 | ROR inverse agonist suppresses insulitis and prevents hyperglycemia in a mouse model of type 1 diabetes |
| Q36650596 | Regulatory T Cells in Melanoma Revisited by a Computational Clustering of FOXP3+ T Cell Subpopulations. |
| Q40108816 | Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it? |
| Q57471979 | Regulatory T cells in the treatment of disease |
| Q33786938 | Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls |
| Q37021626 | Shaping the (auto)immune response in the gut: the role of intestinal immune regulation in the prevention of type 1 diabetes |
| Q37967572 | Suppression assays with human T regulatory cells: a technical guide. |
| Q38014104 | T cell autoreactivity in the transplant milieu. |
| Q47096840 | TH17 Cell Frequency in Peripheral Blood Is Elevated in Overweight Children without Chronic Inflammatory Diseases |
| Q38016854 | TH17 Cells in Autoimmunity and Immunodeficiency: Protective or Pathogenic? |
| Q34756902 | Th1/Th17 plasticity is a marker of advanced β cell autoimmunity and impaired glucose tolerance in humans |
| Q26769612 | Th17 Cells in Type 1 Diabetes: Role in the Pathogenesis and Regulation by Gut Microbiome |
| Q36249305 | The Role of IL-17 and Th17 Lymphocytes in Autoimmune Diseases |
| Q34400478 | The dual role of scavenger receptor class A in development of diabetes in autoimmune NOD mice |
| Q38098467 | Therapeutic potential of regulatory T cells in autoimmune disorders. |
| Q58773667 | Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes |
| Q64066358 | Treg gene signatures predict and measure type 1 diabetes trajectory |
| Q28087084 | Type 1 diabetes and gut microbiota: Friend or foe? |
| Q35123513 | Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes |
| Q61798209 | eIF5A inhibition influences T cell dynamics in the pancreatic microenvironment of the humanized mouse model of Type 1 Diabetes |
Search more.